A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy.
For which of the following data, discovered after the medication was administered, should the nurse file an incident report?
The client had chemotherapy 12 hr before the medication was administered.
The medication vial sat at room temperature for 2 hr before it was administered.
The client’s absolute neutrophil count was 2,500/mm3 before the medication was administered.
The nurse flushed the client’s IV line with dextrose 5% in water before and after the medication was administered.
The Correct Answer is D
The correct answer is d
Choice A reason:
Administering filgrastim 12 hours after chemotherapy does not typically require an incident report. Filgrastim is often given at least 24 hours after chemotherapy to avoid the risk of increasing the toxicity of the chemotherapy agents. While the timing is closer than recommended, it does not necessarily constitute an error unless specific instructions for the timing were provided by the prescribing physician.
Choice B reason:
The medication vial sitting at room temperature for 2 hours before administration does not require an incident report. Filgrastim can be left out at room temperature for up to 24 hours before use. This is within the safe handling guidelines for the medication.
Choice C reason:
An absolute neutrophil count (ANC) of 2,500/mm³ is within the normal range, which is typically 1,500-8,000/mm³. Filgrastim is used to increase neutrophil counts in patients with low ANC due to chemotherapy. Since the ANC was not low before administration, this would not necessitate an incident report, although it may prompt a review of the necessity of the medication.
Choice D reason:
Flushing the client's IV line with dextrose 5% in water before and after the medication was administered is not the standard procedure and could potentially lead to medication errors or adverse effects. Filgrastim should be diluted in glucose 5% in water for intravenous infusion, but not used to flush the line. This deviation from the standard protocol is what necessitates an incident report.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
This is because fentanyl transmucosal is a fast-acting opioid that can be used for breakthrough pain in patients who are already receiving opioids for chronic pain. Breakthrough pain is a sudden and severe increase in pain that occurs despite the use of regular pain medication. Fentanyl transmucosal has a rapid onset of action (1-3 minutes) and a short duration of effect (1-2 hours), which makes it suitable for treating episodic pain.
Choice B. Lidocaine patch is wrong because lidocaine patch is a topical anesthetic that can be used for localized neuropathic pain, but not for acute or severe pain.
Choice C. Morphine tablet is wrong because morphine tablet is a long-acting opioid that can be used for chronic pain, but not for breakthrough pain. Morphine tablet has a slow onset of action (30-60 minutes) and a long duration of effect (3-4 hours), which makes it unsuitable for treating episodic pain.
Choice D. Naloxone IV is wrong because naloxone IV is an opioid antagonist that can reverse the effects of opioids, but not relieve pain.
Naloxone IV can cause
Correct Answer is C
Explanation
Methimazole is an antithyroid medication that blocks the thyroid from making thyroid hormones. It is used to treat hyperthyroidism caused by Graves’ disease, which is an autoimmune disorder that stimulates the thyroid gland to produce excess hormones. After taking methimazole for 2 months, the client should expect to see a reduction in the symptoms of hyperthyroidism, such as weight loss, increased pulse rate, and heat intolerance. Increased sleeping is a sign of improved thyroid function, as hyperthyroidism can cause insomnia and restlessness.
Choice A is wrong because weight loss is a symptom of hyperthyroidism, not a result of methimazole treatment. Methimazole should lower the thyroid hormone levels and help the client gain weight.
Choice B is wrong because an increase in pulse rate is also a symptom of hyperthyroidism, not a result of methimazole treatment. Methimazole should lower the heart rate and blood pressure by reducing thyroid hormone levels.
Choice D is wrong because warmer skin is another symptom of hyperthyroidism, not a result of methimazole treatment. Methimazole should improve the client’s heat tolerance and make the skin cooler and less sweaty.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today